Please note that log in for BLAW products will be unavailable for scheduled maintenance on Sunday, February 5th from approximately 4 AM to 5 AM EST.
Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

LabCorp Sued for Allegedly Infringing DNA Test Patents (1)

Oct. 16, 2020, 6:50 PMUpdated: Oct. 16, 2020, 8:48 PM

LabCorp was sued by Maryland genetic testing company Ravgen Inc. in Texas federal court on Friday for allegedly infringing patents covering non-invasive prenatal DNA testing.

Ravgen owns U.S. Patent Nos. 7,727,720 and 7,332,277, covering methods to detect cell-free fetal DNA from the mother’s blood. Ravgen said the patented technology can be used to replace conventional, invasive prenatal testing for genetic disorders.

The company sued Natera and PerkinElmer in June for allegedly infringing the same two patents.

Laboratory Corporation of America’s MaterniT and InformaSeq prenatal DNA tests and ctDx Lung Assay test for lung cancer patients infringe the patents, Ravgen says. ...